![Emile Nuwaysir](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emile Nuwaysir
Amministratore Delegato presso
Stylus Medicine, Inc.
Profilo
Emile F.
Nuwaysir is the founder of Invenra, Inc. Current positions include Chairman & Chief Executive Officer at Stylus Medicine, Inc. since 2024, Chairman at BlueRock Therapeutics Canada ULC since 2021, and Director at Alliance for Regenerative Medicine since 2023.
Former roles include Chief Executive Officer & Director at Ensoma, Inc., Principal at Quarles & Brady LLP, Chief Technology Officer at Roche Diagnostics Corp., Vice President-Business Development at NimbleGen Systems, Inc. from 2000 to 2008, Principal at The National Institute of Environmental Health Sciences, and Chief Operating Officer, VP-Research & Development at FUJIFILM Cellular Dynamics, Inc. Education includes a doctorate from the University of Wisconsin and an undergraduate degree from the University of Delaware.
Posizioni attive di Emile Nuwaysir
| Società | Posizione | Inizio |
|---|---|---|
BlueRock Therapeutics Canada ULC
 BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Develops induced pluripotent stem cell therapies to cure the diseases | Presidente | 01/08/2021 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Direttore/Membro del Consiglio | 01/01/2023 |
Stylus Medicine, Inc.
 Stylus Medicine, Inc. Medical SpecialtiesHealth Technology Develops therapies | Amministratore Delegato | 01/12/2024 |
Precedenti posizioni note di Emile Nuwaysir
| Società | Posizione | Fine |
|---|---|---|
Invenra, Inc.
 Invenra, Inc. Pharmaceuticals: MajorHealth Technology Develops technology platform for biological drugs | Fondatore | 01/12/2023 |
NimbleGen Systems, Inc.
 NimbleGen Systems, Inc. BiotechnologyHealth Technology Develops micro-arrays used in bio-technology | Corporate Officer/Principal | 30/12/2008 |
Ensoma, Inc.
 Ensoma, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage genomic vivo cellular medicines company | Amministratore Delegato | - |
Quarles & Brady LLP
 Quarles & Brady LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
The National Institute of Environmental Health Sciences
 The National Institute of Environmental Health Sciences Miscellaneous Commercial ServicesCommercial Services Provides biomedical research services | Corporate Officer/Principal | - |
Formazione di Emile Nuwaysir
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
62
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Quarles & Brady LLP
Quarles & Brady LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Invenra, Inc.
Invenra, Inc. Pharmaceuticals: MajorHealth Technology Develops technology platform for biological drugs | Health Technology |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Health Technology |
NimbleGen Systems, Inc.
NimbleGen Systems, Inc. BiotechnologyHealth Technology Develops micro-arrays used in bio-technology | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The National Institute of Environmental Health Sciences
The National Institute of Environmental Health Sciences Miscellaneous Commercial ServicesCommercial Services Provides biomedical research services | Commercial Services |
FUJIFILM Cellular Dynamics, Inc.
 FUJIFILM Cellular Dynamics, Inc. BiotechnologyHealth Technology Manufactures human induced pluripotent stem cells (iPSCs) and iPSC-derived cells for drug discovery | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
BlueRock Therapeutics Canada ULC
BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Develops induced pluripotent stem cell therapies to cure the diseases | Health Technology |
Ensoma, Inc.
Ensoma, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage genomic vivo cellular medicines company | Health Technology |
Stylus Medicine, Inc.
Stylus Medicine, Inc. Medical SpecialtiesHealth Technology Develops therapies | Health Technology |
